Printer Friendly

Articles from Biotech Business (September 1, 2005)

1-4 out of 4 article(s)
Title Author Type Words
CYLENE INITIATES PHASE I CLINICAL TRIAL FOR CX-3543. 427
DOR BIOPHARMA/CAMBREX ACHIEVE RIVAX MILESTONE. 655
EXELIXIS INITIATES PHASE I CLINICAL TRIAL FOR ANTICANCER XL820. 644
MYOGEN COMPLETES ENROLLMENT FOR PHASE 3 ARIES-2 TRIAL. 828

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters